Cargando…
Erratum: Cefiderocol for the Treatment of Multidrug-Resistant Gram-Negative Bacteria: A Systematic Review of Currently Available Evidence
Autor principal: | Frontiers Production Office |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434632/ https://www.ncbi.nlm.nih.gov/pubmed/36060008 http://dx.doi.org/10.3389/fphar.2022.976792 |
Ejemplares similares
-
Cefiderocol for the Treatment of Multidrug-Resistant Gram-Negative Bacteria: A Systematic Review of Currently Available Evidence
por: Wang, Chuanhai, et al.
Publicado: (2022) -
Erratum: Current Advances in Coptidis Rhizoma for Gastrointestinal and Other Cancers
por: Frontiers Production Office,
Publicado: (2022) -
Erratum: Drug resistance mechanism of kinase inhibitors in the treatment of hepatocellular carcinoma
por: Frontiers Production Office,
Publicado: (2023) -
Erratum: Wnt-pathway inhibitors with selective activity against triple-negative breast cancer: From thienopyrimidine to quinazoline inhibitors
por: Frontiers Production Office,
Publicado: (2023) -
Erratum: Chinese Herbal Medicine for Psoriasis: Evidence from 11 High-Quality Randomized Controlled Trials
por: Frontiers Production Office,
Publicado: (2021)